MedTrace Logo

Analysis of Q10 Coenzyme Efficacy for Long-term Treatment of Cyclic Vomiting Syndrome in Children

NCT03295760 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2017-09-28

No results posted yet for this study

Summary

The main purpose of this study is the comparison of frequency of vomiting episodes (number of episodes per year) observed during the year after the begin of Q10 coenzyme treatment to frequency observed during the year before the begin of this treatment in children with cyclic vomiting syndrome.

Secondary purposes are the evaluation of life quality of parents and children, of treatment safety and its economic cost compared to other recommended treatments.

Conditions

  • Cyclic Vomiting Syndrome

Interventions

DRUG

Q10 Coenzyme

Sponsors & Collaborators

  • Central Hospital, Nancy, France

    lead OTHER

Eligibility

Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-01
Primary Completion
2017-07-31
Completion
2017-07-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03295760 on ClinicalTrials.gov